Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma?

Annals of Oncology

Volumn 8, Issue 10, 1997, Pages 1023-1029

  Van Der Valk, P ^a   Lindeman, J ^b   Kamphorst, W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Double staining; Glioma; Growth factors; Immunohistochemistry

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CANCER GRADING; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ASTROCYTOMA; AUTOCRINE COMMUNICATION; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL DIVISION; GLIOBLASTOMA; GLIOMA; GROWTH SUBSTANCES; HUMANS; OLIGODENDROGLIOMA; PARACRINE COMMUNICATION;

EID: 0030662280     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008265905505     Document Type: Article

References (34)

1. Lund-Johansen M, Bjerkvig R, Humphrey PA et al. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 1990; 50: 6039-44.
2. Anderson DJ. New roles for PDGF and CNTF in controlling the timing of glial cell differentiation in the optic nerve. TINS 1989; 12: 83-5.
3. Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm- and neuroectoderm-derived cells. Cell Differ 1986; 19: 1-17.
4. Noble M, Murray K, Stroobant P et al. Platelet-derived growth factor promotes division and motility and inhibits differentiation of the oligodendrocyte/type 2 astrocyte progenitor cell. Nature 1988; 333: 560-2.
5. Merzak A, Koochekpour S, Dkhissi F et al. Synergism between growth factors in the control of glioma cell proliferation, migration and invasion in vitro. Int J Oncol 1995; 6: 1079-85.
6. Pringle N, Collarini EJ, Mosley MJ et al. PDGFA chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. EMBO J 1989; 8: 1049-56.
7. Westphal M, Brunken M, Rohde E, Herrman H-D. Growth factors in cultured human glioma cells: Differential effects of FGF, EGF and PDGF. Cancer Lett 1988; 38: 283-96.
8. Okumura N, Takimoto K, Okada M, Nagakawa H. C6 glioma cells produce basic fibroblast growth factor that can stimulate their own proliferation. J Biochem 1989; 106: 904-9.
9. Merrill MJ, Edwards NA. Insulin-like growth factor-I receptors in human glial tumours. J Clin Endocrinol Metab 1990; 71: 199-209.
10. Mapstone T, McMichael M, Goldthwait D. Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in a variety of primary human brain tumours. Neurosurgery 1991; 28: 216-22.
11. Maxwell M, Naber SP, Wolfe HJ et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991; 51: 1345-51.
12. Takahashi JA, Suzui H, Yasuda Y et al. Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. Biochem Biophys Res Comm 1991; 177: 1-7.
13. Torp SH, Helseth E, Dalen A, Unsgaard G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 1991; 33: 61-4.
14. Tuzi NL, Venter DJ, Kumar S et al. Expression of growth factor receptors in human brain tumours. Br J Cancer 1991; 63: 227-33.
15. Constam DB, Philipp J, Malipiero UV et al. Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes, and microglia. J Immunol 1992; 148: 1404-10.
16. Fleming TP, Saxena A, Clark WC et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumours. Cancer Res 1992; 52: 4550-3.
17. Gillaspy GE, Mapstone TB, Samols D, Goldthwait DA. Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells. Cancer Lett 1992; 65: 55-60.
18. Hermanson M, Funa K, Hartman M et al. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52: 3213-9.
19. Sporn MB, Roberts AB. Autocrine, paracrine and endocrine mechanisms of growth control. Cancer Surv 1985; 4: 627-32.
20. Couldwell WT, Fraser G, De Vellis G et al. Malignant gliomaderived soluble factors regulate proliferation of normal adult human astrocytes. J Neuropathol Exp Neurol 1992; 51: 506-13.
21. Lund-Johansen M, Forsberg K, Bjerkvig R, Laerum O-D. Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 1992; 84: 190-7.
22. Helseth E, Unsgaard G, Dalen A, Vik R. The effects of β-transforming growth factor on the proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line. J Neuro Oncol 1988; 6: 277-83.
23. Takahashi JA, Mori H, Fukumoto M et al. Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumour tissues. Proc Natl Acad Sci USA 1990; 87: 5710-4.
24. Roberts AB, Kim S-J, Noma T et al. Multiple forms of TGF-β: Distinct promoters and differential expression. CIBA Found Symp 1991; 157: 7-28.
25. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-68.
26. Mullink H, Henzen-Logmans SC, Alons-van Kordelaar JJM et al. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma. Virchows Arch B 1986; 52: 55-65.
27. Maarsseveen ACTM van, Mullink H, Haan M de et al. Simultaneous enumeration of T-cell subsets and macrophages in bronchoalveolar fluids by immunoenzyme double staining. Comparison with conventional immunofluorescence. Acta Cytol 1989; 33: 550-6.
28. Zaheer A, Zhong W, Uc EY et al. Expression of mRNA's of multiple growth factors and receptors by astrocytes and glioma cells: Detection with reverse transcriptase-polymerase chain reaction. Cell Mol Neurobiol 1995; 15: 221-37.
29. Westphal M, Herrmann H-D. Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 1989; 25: 681-94.
30. Reifenberger G. Immunhistochemie der Tumoren des Nerven-systems. Berlin: Springer-Verlag 1991; 99-104.
31. Schwechheimer K, Huang S, Cavenee WK. EFGR gene amplification-rearrangement in human glioblastoma. Int J Cancer 1995; 62: 145-8.
32. Rorsman F, Leveen P, Betsholz C. Platelet-derived growth factor (PDGF) A-chain mRNA heterogeneity generated by the use of alternative promoters and alternative polyadenylation sites. Growth Factors 1992; 7: 241-51.
33. Kuratsu J-I, Ushio Y. Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 1990; 73: 436-40.
34. Baird A, Mormede P, Bohler P. Immunoreactive fibroblast growth factor in transplantable rat chondrosarcoma: Inhibition of tumour growth by antibodies to fibroblast growth factor. J Cell Biochem 1986; 30: 365-70.